Stem Lowers FY2024 Sales Guidance from $200.00M-270.00M to $135.00M-155.00M VS Est. 225.15M
Portfolio Pulse from Benzinga Newsdesk
Stem has revised its FY2024 sales guidance downward from $200-270 million to $135-155 million, which is significantly below the estimated $225.15 million.
October 30, 2024 | 9:25 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Stem has significantly lowered its FY2024 sales guidance, which is now well below market estimates. This could negatively impact investor sentiment and the stock price in the short term.
The downward revision of sales guidance from $200-270 million to $135-155 million is a significant reduction and is below the market estimate of $225.15 million. This suggests potential challenges in revenue generation, which could lead to negative investor sentiment and a decline in stock price.
CONFIDENCE 95
IMPORTANCE 90
RELEVANCE 100